Top

Published in:

01-05-2007 | Original Research Article

Evidence of a possible impact of the menstrual cycle on the reproducibility of scotopic ERGs in women

Authors: Julie Brûlé, Marie-Pier Lavoie, Christian Casanova, Pierre Lachapelle, Marc Hébert

Published in: Documenta Ophthalmologica | Issue 3/2007

Abstract

The purpose of this study was to investigate the impact of gender and menstrual cycle on the electroretinogram (ERG). Photopic and scotopic ERGs were obtained in 14 females during the luteal and follicular phases of their menstrual cycle and compared to those obtained on two separate (7 days or 14 days apart) sessions from seven age-matched control male subjects. Our results confirm that the amplitude of the photopic ERGs of females is significantly (P < 0.05) larger than males, and this, irrespective of the cycle phase. In comparison, scotopic ERGs revealed significant male–female differences only during the follicular phase. While in males, no significant (P > 0.05) intersession (7 day or 14 day intervals) variability could be demonstrated, significant (P < 0.001) intersession (luteal–follicular) variability was observed in the scotopic ERGs of our female participants, with 8 of the 14 women, demonstrating a marked increase of 20.17 ± 4.8% in the follicular ERG compared to the luteal. Our data suggests there should be separate normal ERG values for men and women and that the phase of the menstrual cycle should be taken into consideration when interpreting the ERG results from women.

Karpe G, Rickenbach K, Thomasson S (1950) The clinical electroretinogram I. The normal electroretinogram above fifty years of age. Acta Ophthalmol 28:301–305

Vainio-Mattila B (1951) The clinical electroretinogram. Acta Ophthalmol 29:25–32

Peterson H (1968) The normal B-potential in the single-flash clinical electroretinogram. A computer technique study of the influence of sex and age. Acta Ophthalmol (Copenh.) Suppl 99:7–77

Zeidler I (1959) The clinical electroretinogram II. The difference between the electroretinogram in men and women. Acta Ophthalmol 37:294–301

Hébert M, Fishman G, Lachapelle P (1999) Gender differences in ERG amplitude recorded with the DLT electrode. Invest Ophthalmol Vis Sci. 40:S15

Pallin O (1969) The influence of the axial length of the eye on the size of the recorded b-potential in the clinical single-flash electroretinogram. Acta Ophthalmol Suppl 101:2–48

Barris M, Dawson W, Theiss C (1980) The visual sensitivity of women during the menstrual cycle. Doc Ophthalmol 49:293–301PubMedCrossRef

Bassi C, Powers M (1986) Daily fluctuations in the detectability of dim lights by humans. Physiol Behav 38:871–877PubMedCrossRef

Guttridge N (1994) Changes in ocular and visual variables during the menstrual cycle. Ophthal Physiol Opt 14:38–48

10.

Tserotas K, Merino G (1998) Andropause and the aging male. Arch Androl 40:87–93PubMed

11.

Eye disease case-control study group (1994) Risk factors for idiopathic macular holes. Am J Ophthalmol 118:754–761

12.

Evans J, Schwartz S, McHugh J et al (1998) Systemic risk factors for idiopathic macular holes: a case-control study. Eye 12:256–259PubMed

13.

Klein B, Klein R, Lee K (1998) Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the beaver dam eye study. Am J Ophthalmol 126:782–790PubMedCrossRef

14.

Mathers W, Stovall D, Lane J, Zimmerman M, Johnson S (1998) Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea 17:353–358PubMedCrossRef

15.

Klein B, Klein R, Ritter L (1994) Is there evidence of an estrogen effect on age-related lens opacities. Arch Ophthalmol 112:85–91PubMed

16.

Eye disease case-control study group (1992) Risk factors for neovascular age-related macular degeneration. Am J Ophthalmol 110:1701–1708

17.

Lachapelle P, Benoit J, Little J, Lachapelle B (1993) Recording the oscillatory potentials of the electroretinogram with the DTL electrode. Doc Ophthalmol 83:119–130PubMedCrossRef

18.

Hébert M, Lachapelle P, Dumont M (1996) Reproducibility of electroretinograms recorded with DTL electrodes. Doc Ophthalmol 91:333–342CrossRef

19.

Marmor M, Zrenner E (1999) Standard for clinical electroretinography (1999 update). Doc Ophthalmol 89:199–210CrossRef

20.

Marmor M, Fishman G (1989) A standard electroretinography protocol. Arch Ophthalmol 107:813–814PubMed

21.

Peachey N, Alexander K, Fishman G, Derlacki D (1989) Properties of the human cone system electroretinogram during light adaptation. Appl Optics 28:1145–1150

22.

Lachapelle P (1987) Analysis of the photopic electroretinogram recorded before and after dark adaptation. Can J Ophthalmol 22:354–361PubMed

23.

Wali N, Leguire L (1992) The photopic hill: a new phenomenon of the light adapted electroretinogram. Doc Ophthalmol 80:335–342PubMedCrossRef

24.

Wali N, Leguire L (1993) Fundus pigmentation and the electroretinographic luminance-response function. Doc Ophthalmol 84:61–69PubMedCrossRef

25.

Rufiange M, Dassa J, Dembinska O et al (2003) The photopic ERG luminance-response function (photopic hill: method of analysis and clinical application. Vision Res 43:1405–1412PubMedCrossRef

26.

Hankins M, Jones S, Jenkins A, Morland A (2001) Diurnal daylight phase affects the temporal properties of both the b-wave and d-wave of the human electroretinogram. Brain Res 889:339–343PubMedCrossRef

27.

Birch D, Berson E, Sandberg M (1984) Diurnal rhythm in the human rod ERG. Invest Ophthalmol Vis Sci 25:236–238PubMed

28.

Birch D, Sandberg M, Berson E (1986) Diurnal rhythm in the human rod ERG relationship to cyclic lighting. Invest Ophthalmol Vis Sci 27:268–270PubMed

29.

Nozaki S, Wakakura M, Ishikawa S (1983) Circadian rhythm of human electroretinogram. Jpn J Ophthalmol 27:346–352PubMed

30.

Rufiange M, Dumont M, Lachapelle P (2002) Correlating retinal function with melatonin secretion in subjects with an early or late circadian phase. Invest Ophthalmol Vis Sci 43:2491–2499PubMed

31.

Lachapelle P (1994) The human suprathreshold photopic oscillatory potentials: method of analysis and clinical application. Doc Ophthalmol 88:1–25PubMedCrossRef

32.

Rufiange M, Rousseau S, Dembinska O, Lachapelle P (2002) Cone-dominated ERG luminance-response function: the Photopic Hill revisited. Doc Ophthalmol 104:231–248PubMedCrossRef

33.

Gouras P, MacKay C (1989) Growth in amplitude of the human cone electroretinogram with light adaptation. Invest Ophthalmol Vis Sci 30:625–630PubMed

34.

Rousseau S, Lachapelle P (2000) Transient enhancing of cone electroretinograms following exposure to brighter photopic backgrounds. Vision Res 40:1013–1018PubMedCrossRef

35.

Hébert M, Vaegan, Lachapelle P (1999) Reproducibility of ERG responses obtained with the DTL electrode. Vision Res 39:1069–1070PubMedCrossRef

36.

Brown K (1968) The electroretinogram: its components and their origins. Vision Res 8:633–677PubMedCrossRef

37.

Wachtmeister L (1980) Further studies of the chemical sensitivity of the oscillatory potentials of the electroretinogram (ERG) I. GABA and glycine antagonists. Acta Ophthalmol 58:712–725CrossRef

38.

Wachtmeister L, Je D (1978) The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 17:1176–1188PubMed

39.

Lachapelle P (1990) A possible contribution of the optic nerve to the photopic oscillatory potentials. Clin Vision Sci 5:421–426

40.

Lachapelle P, Little J, Polomeno R (1983) The photopic electroretinogram in congenital stationary night blindness with myopia. Invest Ophthalmol Vis Sci 24:442–450PubMed

41.

Lachapelle P (1991) Evidence for an intensity coding oscillatory potential in the human electroretinogram. Vision Res 31:767–774PubMedCrossRef

42.

Munaut C, Lambert V, Noël A et al (2001) Presence of oestrogen receptor type B in human retina. Br J Ophthalmol 85:877–882PubMedCrossRef

43.

Ogueta S, Schwartz S, Yamashita C, Farber D (1999) Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 40:1906–1911PubMed

44.

Richardson P, Nichols C, Parsons M, Rennie I (1995) Sex steroid hormone receptors in the human retina and choroid: an immunocytochemical study. Invest Ophthalmol Vis Sci 36:S128

45.

Henkes H (1951) The use of electroretinography in measuring the effects of vasodilatation. Angiology 2:125–131PubMed

46.

Sullivan D, Edwards J, Wickham A, Pena J, Gao J, Ono M (1996) Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res 15:279–291PubMed

47.

Wickham A, Gao J, Toda I, Rocha E, Ono M, Sullivan D (2000) Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 78:146–153PubMedCrossRef

48.

Suzuki T, Kinoshita Y, Tachibana M et al (2001) Expression of sex steroid hormone receptors in human cornea. Curr Eye Res 22:28–33PubMedCrossRef

Title: Evidence of a possible impact of the menstrual cycle on the reproducibility of scotopic ERGs in women
Authors: Julie Brûlé
Marie-Pier Lavoie
Christian Casanova
Pierre Lachapelle
Marc Hébert
Publication date: 01-05-2007
Publisher: Springer-Verlag
Published in: Documenta Ophthalmologica / Issue 3/2007
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI: https://doi.org/10.1007/s10633-007-9045-1

At a glance: The STEP trials

Springer Medicine

Evidence of a possible impact of the menstrual cycle on the reproducibility of scotopic ERGs in women

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2007

In diabetic retinopathy, foveal thickness of 300 μm seems to correlate with functionally significant loss of vision

ISCEV standard for clinical pattern electroretinography—2007 update

Predicting potential acuities in amblyopes

Multifocal electroretinogram for assessing sun damage following the solar eclipse of 29 March 2006

Choroideremia carriers maintain a normal electro-oculogram (EOG)

Branch retinal artery occlusion associated with compound heterozygous genotype for methylenetetrahydrofolate reductase